UnitedHealth Group (NYSE:UNH) released its quarterly earnings data on Tuesday. The healthcare conglomerate reported $3.04 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.13, Bloomberg Earnings reports. The firm had revenue of $55.19 billion for the quarter, compared to analysts’ expectations of $54.90 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The firm’s quarterly revenue was up 13.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.37 earnings per share.

NYSE UNH opened at $230.32 on Tuesday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group has a 1 year low of $164.96 and a 1 year high of $250.79. The firm has a market capitalization of $217,027.44, a price-to-earnings ratio of 22.25, a P/E/G ratio of 1.31 and a beta of 0.77.

How to Become a New Pot Stock Millionaire

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were paid a $0.75 dividend. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.30%. UnitedHealth Group’s dividend payout ratio is presently 29.79%.

A number of analysts have issued reports on the company. Deutsche Bank boosted their target price on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Evercore ISI reissued an “outperform” rating and issued a $255.00 target price (up previously from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Piper Jaffray reissued a “buy” rating and issued a $259.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. BMO Capital Markets boosted their target price on UnitedHealth Group from $14.50 to $275.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a research report on Tuesday, January 16th. Three investment analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $244.62.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the transaction, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the transaction, the insider now owns 173,229 shares of the company’s stock, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. Insiders sold 77,015 shares of company stock valued at $17,879,199 in the last 90 days. 0.89% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Maverick Capital Ltd. acquired a new position in UnitedHealth Group in the second quarter valued at $4,048,000. Kingdon Capital Management L.L.C. acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $13,841,000. Arrowstreet Capital Limited Partnership boosted its stake in shares of UnitedHealth Group by 30.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,303,068 shares of the healthcare conglomerate’s stock worth $241,615,000 after buying an additional 300,744 shares during the period. Tower Research Capital LLC TRC boosted its stake in shares of UnitedHealth Group by 3,881.4% during the second quarter. Tower Research Capital LLC TRC now owns 6,211 shares of the healthcare conglomerate’s stock worth $1,152,000 after buying an additional 6,055 shares during the period. Finally, Coldstream Capital Management Inc. boosted its stake in shares of UnitedHealth Group by 37.8% during the second quarter. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate’s stock worth $315,000 after buying an additional 466 shares during the period. Institutional investors own 86.78% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.dailypolitical.com/2018/04/17/unitedhealth-group-unh-issues-earnings-results-beats-estimates-by-0-13-eps.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.